ReviewInternational journal of molecular sciences2020
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Alex Friedlaender et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this paperpooled itcites it